About the Company
We do not have any company description for Protara Therapeutics, Inc. at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on Protara Therapeutics, Inc.
Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq ...
NEW YORK, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA) (“Protara” or the “Company”), a clinical-stage company developing transformative therapies for the ...
A Protara Therapeutics, Inc. (NASDAQ:TARA) insider increased their ...
Insiders were net buyers of Protara Therapeutics, Inc.'s (NASDAQ:TARA ) stock during the past year. That is, insiders bought more stock than they sold. Although we don't think shareholders should ...
Protara Therapeutics, Inc. Added to Russell 3000® Index ... - Nasdaq
Protara Therapeutics, Inc. has been added to the Russell 3000® Index as of June 30, 2025, marking a significant milestone for the clinical-stage biotechnology company focused on developing ...
Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq ...
Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635 (c) (4) Provided by GlobeNewswire May 1, 2025, 1:09:55 PM ...
Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq ...
NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA) (“Protara” or the “Company”), a clinical-stage company developing transformative therapies for the treatment of ...
Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq ...
NEW YORK, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA) (“Protara” or the “Company”), a clinical-stage company developing transformative therapies for the treatment of ...
Protara Therapeutics, Inc. Reports Inducement Grant Under Nasdaq ...
NEW YORK, June 24, 2024 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (TARA), a clinical stage company developing transformative therapies for the treatment of cancer and rare diseases, today ...
Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq ...
NEW YORK, April 19, 2021 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical stage company developing transformative therapies for the treatment of cancer and rare diseases ...
Similar Companies
Loading the latest forecasts...